drugset / Trial / NCT00128271
Study of Bavituximab in Patients With Chronic Hepatitis C Virus Infection
Non-randomizedSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to determine the safety and tolerability of bavituximab when administered via a vein as a single infusion and to examine how bavituximab behaves in the body and how it affects the amount of hepatitis C virus in individuals with chronic infection.
Timeline
- Start
- 2005-08
- Primary completion
- 2006-08
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Bavituximab | Monoclonal antibody | — | Intravenous |